Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
CA 2505529 C · Owner: Massachusetts Institute Of Technology · Inventors: Mahmood, Ashfaq; Davison, Alan; Jones, Alun G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment the invention relates the , methods of imaging tissues organs or tumors using radiolabeled metal complexes, particularly tissues, organs or tumors which express certain , receptors to which the compounds or complexes of the invention have an affinity. The present invention also relates to methods of treating cancer particularly those cancer lines which express certain receptors to which the compounds or complexes of the invention have an affinity. In yet another embodiment, the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 8, 2003 and granted December 24, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 8, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 8, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.